Publications 2013 – 2010

| 2016 thru 2014 | 2013 | 2012 | 2011 | 2010 | 2009 thru 2006 | 2005 thru 2001 |

 

2013

  1. Stuckey, D., Shah, K. TRAIL on trial: preclinical advances for cancer therapy. Trend MOL MED. 2013 Jul 23. PMID: 24076237
  2. Shah K. Encapsulated stem cells for cancer therapy. Biomatter. 2013 Jan 1;3(1). doi:pii: e24278. [Epub ahead of print]. PMID: 23507920
  3. Martinez-Quintanilla J, Bhere D, Heidari P, He D, Mahmood U, Shah K. In vivo imaging of the therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors. Stem Cells. 2013 Feb 6. doi: 10.1002/stem.1355. [Epub ahead of print]. PMID: 23389839
  4. Hingtgen S, Figueiredo JL, Farrar C, Duebgen M, Martinez-Quintanilla J, Bhere D and Shah K. Real-time multi-modality imaging of glioblastome tumor resection and recurrence. 2012 J Neurooncol.[Epub ahead of print] PMID: 23242736
  5. Book: Stem Cell Therapeutics for Cancer. Editor- Khalid Shah. Wiley-Blackwell 2013

2012

  1. Van de Water JA, Bagci-Onder T, Agarwal AS, Wakimoto H, Roovers RC, Zhu Y, Kasmieh R, Bhere D, Van Bergen En Henegouwen PM, Shah K. Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.2012. Proc Natl Acad Sci U S A. [Epub ahead of print] PMID:23012408
  2. Tamura K, Wakimoto H, Agarwal A, Rabkin SD, Martuza RL, Kuroda T, Kasmieh R and Shah K, Multi-mechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors.2012 Mol. Ther.[Epub ahead of print]. PMID: 22929661.
  3. Kauer TM, Figueiredo JL, Hingtgen S, Shah K. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. 2012. Nat Neurosci. PMID: 22197831 Research Highlight: Drug Delivery: Flight, MH. Encapsulation improves therapeutic stem cell action, Nat. Review Drug Discovery 2012, 11, 106-107.
  4. Hingtgen SD, Kasmieh R, El-Bayly E, Nesterenko I, Figueiredo JL, Dash R, Sarkar D, Hall D, Kozakov D, Vadja S, Fisher PB and Shah K. A first generation multi-funtional cytokine for simulataneous optical tracking and tumor therapy. 2012 PLoS ONE.PMID: 22808125
  5. Bagci-onder T, Agarwal A, Flusberg D, Wanningen S, Sorger P and Shah K. Real time imaging of the dynamics of death receptors and combinatorial therapies that overcome TRAIL resistance in tumors.2012 Oncogene. [Epub ahead of print] PMID: 22824792
  6. Nesterenko I, Wanningen S, Bagci-onder T, Anderegg M and Shah K. Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas. 2012 PLoS ONE.[Epub ahead of print] PMID: 23145127

2011

  1. Shah K. In vivo imaging of the dynamics of different variants of EGFR in glioblastomas. Methods Mol Biol. 2011;680:153-64.PMID: 21153380[PubMed – in process]
  2. Shah K. Imaging fate of stem cells at a cellular resolution in the brains of mice. Methods Mol Bio. 2011;680:91 – 101.PMID: 21153375 [PubMed – in process]
  3. Bagci-Onder T, Wakimoto H, Anderegg M, Cameron C, Shah K. A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell delivered TRAIL in experimental glioma models. Cancer Res. 2010 Nov 17. [Epub ahead of print] PMID: 21084267 [PubMed – as supplied by publisher]
  4. Shah K. Mesenchymal Stem Cells engineered for cancer therapy. Adv Drug Deliv Rev. 2011 Jun 29. [Epub ahead of print] PMID: 21740940 [PubMed – as supplied by publisher]
  5. Carney BJ, Shah K. Migration and fate of therapeutic stem cells in different brain disease models. Neuroscience. 2011:ePub PMID: 21946010

2010

  1. Hingtgen SD, Kasmieh R, van de Water J, Weissleder R, Shah K. Determining Multiple Aspects of Stem Cell-Based Therapies Using Novel Diagnostic and Therapeutic Multifunctional Molecules. Stem Cells. 2010;:ePub – PMID: 20127797
  2. Yoo BK, Chen D, Su ZZ, Gredler R, Yoo J, Shah K, Fisher PB, Sarkar D. Molecular Mechanism of Chemoresistance by Astrocyte Elevated Gene-1. Cancer Res. 2010;70(8):3249-58 – PMID: 20388796 – PMCID: PMC2855753
  3. Van Eekelen M, Sasportas LS, Kasmieh R, Yip S, Figueiredo JL, Louis DN, Weissleder R, Shah K. Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. Oncogene. 2010, ePub – PMID:20305695
  4. Hamed HA, Yacoub A, Park MA, Eulitt PJ, Dash R, Sarkar D, Dmitriev IP, Lesniak MS, Shah K, Grant S, Curiel DT, Fisher PB, Dent P. Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant Glioma. Mol Ther. 2010, ePub – PMID: 20179672
  5. Emdad L, Sarkar D, Lee SG, Su ZZ, Yoo BK, Dash R, Yacoub A, Fuller CE, Shah K, Dent P, Bruce JN, Fisher PB. Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther. 2010;9(1):79-88 – PMID: 20053777